Ambiopharm Announces New Senior Director of Manufacturing

North Augusta, SC, December 05, 2018 --(PR.com)-- North Augusta, S.C.: Ambiopharm Inc., a leading manufacturer of peptide active pharmaceutical ingredients APIs), is pleased to announce the addition of Mukesh Patel, M.S. as the Senior Director of Peptide Manufacturing at its North Augusta, SC facility. Mr. Patel has a MS degree in Organic Chemistry and more than 30 years of industrial peptide experience with the other leading peptide manufacturing companies.

Dr. Chris Bai, President and CEO, of Ambiopharm states, “We are very pleased to have such a talented and distinguished peptide chemist join our company. As our company continues to grow at a very rapid pace, we need experienced and talented scientists like Mr. Patel.” Ambiopharm is currently expanding its peptide manufacturing facilities both in Shanghai, China and its US headquarters in North Augusta, SC. “This is an exciting time for Ambiopharm as we are creating hundreds of good jobs for people in both countries and improving the lives of patients all around the world,” says Dr. Bai. The accelerated growth of Peptide API manufacturing is attributed to several very successful peptide-based drugs used for treating certain diseases such as type 2 diabetes and chronic constipation.